SWK Holdings Corp
NASDAQ:SWKH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Omesti Bhd
KLSE:OMESTI
|
MY |
|
H
|
HOV Services Ltd
NSE:HOVS
|
IN |
|
Securitas AB
STO:SECU B
|
SE |
|
Multitude Se
XETRA:E4I
|
MT |
|
G
|
Gilat Telecom Global Ltd
TASE:GLTL
|
IL |
|
Sonic Automotive Inc
NYSE:SAH
|
US |
|
H
|
Holly Futures Co Ltd
HKEX:3678
|
CN |
SWK Holdings Corp
Total Current Liabilities
SWK Holdings Corp
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SWK Holdings Corp
NASDAQ:SWKH
|
Total Current Liabilities
$5m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
20%
|
|
|
LM Funding America Inc
NASDAQ:LMFA
|
Total Current Liabilities
$9.9m
|
CAGR 3-Years
71%
|
CAGR 5-Years
68%
|
CAGR 10-Years
N/A
|
|
|
A-Mark Precious Metals Inc
NASDAQ:AMRK
|
Total Current Liabilities
$1.5B
|
CAGR 3-Years
36%
|
CAGR 5-Years
17%
|
CAGR 10-Years
17%
|
|
|
S
|
Standard Premium Finance Holdings Inc
OTC:SPFX
|
Total Current Liabilities
$49.7m
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
SUI Group Holdings Ltd
NASDAQ:SUIG
|
Total Current Liabilities
$12.7m
|
CAGR 3-Years
151%
|
CAGR 5-Years
84%
|
CAGR 10-Years
66%
|
|
SWK Holdings Corp
Glance View
SWK Holdings Corp. is engaged in the business of financial and asset management in the field of pharmaceutical. The company is headquartered in Dallas, Texas and currently employs 35 full-time employees. The firm is focused on providing various capital solutions to a range of life science companies, institutions and inventors. The firm operates through two segments: Finance Receivables and Pharmaceutical Development. Its Finance Receivables segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. In addition, through its wholly owned subsidiary, SWK Advisors LLC, it provides non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. Through its subsidiary, Enteris BioPharma, Inc., its Pharmaceutical Development segment offers formulation solutions built around its oral drug delivery technology, the Peptelligence platform.
See Also
What is SWK Holdings Corp's Total Current Liabilities?
Total Current Liabilities
5m
USD
Based on the financial report for Dec 31, 2025, SWK Holdings Corp's Total Current Liabilities amounts to 5m USD.
What is SWK Holdings Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
20%
Over the last year, the Total Current Liabilities growth was -11%. The average annual Total Current Liabilities growth rates for SWK Holdings Corp have been -8% over the past three years , -20% over the past five years , and 20% over the past ten years .
